Cybrin®

Palbociclib

Product Information

  • Proprietary Name: Cybrin®
  • Generic Name: Palbociclib
  • Dosage Form: Hard Gelatin Capsule
  • Strengths: 75 mg, 100 mg, 125 mg
  • Indications: Breast Cancer
Download Leaflet

Oncology

Cybrin®

Palbociclib is indicated for the treatment of breast cancer.

Apply for a Job Position

Curious about job opportunities?

Signup for a job

Products

Support

Company

Follow Us

© NanoAlvand. All rights reserved. Powered by ِDGN.